Abu Dhabi's traditional and complementary medicine centres have twelve months to integrate with Malaffi. The public list of facilities required to connect has not caught up, and diligence run off it will miss the obligation entirely.
DoH Circular No. 171/2026, dated 4 September 2026 and signed by the Undersecretary, gives every traditional, complementary and alternative medicine centre in Abu Dhabi twelve months from issuance to complete technical integration with Malaffi, submit all required patient records and clinical data, and clear anything blocking either. On expiry the licence of a non-compliant centre will not be renewed. Malaffi's own public table of facilities required to connect, checked on 22 September 2026, still shows the category as not required. A buyer running regulatory diligence off that table gets the wrong answer, and inherits a licence-renewal condition the seller may never have been told about.
What a board member needs before the next meeting on this.
- The obligation is new and the public record has not moved. Circular 171/2026 of 4 September 2026 requires every TCAM centre to integrate with Malaffi. On 22 September 2026 Malaffi's facilities-required-to-connect table still listed traditional, complementary and alternative medicine as not required, under a note that DoH may modify the list at any time.
- The sanction is the licence, not a fine. On expiry of the twelve-month grace period, the licence of a non-compliant centre will not be renewed. There is no penalty schedule to price and no fine to absorb as a cost of delay.
- Integration is an EMR project, not a registration. The circular requires completed technical integration, submission of all required patient records and clinical data, and resolution of anything blocking either. A single-site clinic running practice software chosen for billing has work to scope, and Malaffi's onboarding team is the route.
- The deadline is arithmetic, not a stated date. The circular grants twelve months from its issuance date of 4 September 2026. It does not print a deadline. September 2027 is the reading, and the safer covenant language ties to the circular's period rather than to a date the instrument never gives.
The Department of Health – Abu Dhabi issued Circular No. 171/2026 on 4 September 2026, addressed to all traditional, complementary and alternative medicine centres in the emirate and signed by the Undersecretary, Dr Noura Khamis Al-Ghaithi (DoH circulars). It requires those centres to complete their integration with Malaffi and to submit all required patient data.
Centres that have not yet integrated are granted a grace period of twelve months from the date of issuance, during which they must complete the technical integration, submit all required patient records and clinical data, and resolve any technical or operational issues preventing compliance. On expiry, the licence of any centre that has not complied will not be renewed.
The published list still says the opposite
Malaffi maintains a public table of the facility types required to connect, and it is the page a diligence team finds first. Fetched on 22 September 2026, eighteen days after the circular, its row for traditional, complementary and alternative medicine reads "All" and "No" (Malaffi, facilities required to connect).
The same page states that the deadline for facilities with an active DoH licence has closed and that non-exempt facilities which have not connected will not be able to renew their DoH licence, and it carries DoH's own caveat that the list may be modified at any point in time. Both statements are true as published.
Read together on the wrong day, they tell a buyer that a TCAM target has no Malaffi obligation and no renewal exposure, which as of 4 September 2026 is wrong on both counts.
Why the category sat outside
Malaffi has been the Abu Dhabi health information exchange since 2019, and the mandate to connect arrived by facility class rather than all at once. Hospitals, clinics of most kinds, diagnostic and dialysis centres, IVF centres, pharmacies, home care and telemedicine providers were brought in.
TCAM sat with the categories marked not required, alongside scientific offices, dental laboratories and optical shops. The exemption was sequencing, not a judgment that the data did not matter, and the circular closes it. Ayurveda, acupuncture, homeopathy, Chinese medicine and naturopathy practices in Abu Dhabi now sit under the same exchange obligation as a clinic.
Get the instruments that touch your licence, assessed, as they are issued. See Regulatory Watch
Integration is a project with a vendor in it
The circular does not ask a centre to register or to sign an undertaking. It asks for completed technical integration and for the submission of all required patient records and clinical data. In practice that means a clinical system capable of sending the data set the exchange expects, in the coding standards it expects, and a body of historic records in a state fit to send.
Larger TCAM groups with a proper electronic medical record have a configuration exercise. A single-site centre running practice-management software chosen for appointments and invoicing may find the answer is a system replacement, and the cost of that is not the integration fee. The third duty, resolving anything preventing compliance, puts the obligation to fix on the centre rather than on its vendor.
The deadline is a period, not a date
The circular grants twelve months from its issuance date and prints no deadline. Counting from 4 September 2026 gives September 2027, and that is our arithmetic rather than a date the instrument states. The distinction is worth keeping in the drafting. A covenant tied to "the expiry of the grace period under DoH Circular 171/2026" survives a clarification or an extension; one tied to a date we computed does not.
It is also worth noting how differently two consecutive DoH circulars are enforced: the Sahatna circular issued days earlier names no penalty at all, while this one writes licence non-renewal into the text. Neither the number nor the date tells you which kind you are reading.
What this does to a deal
Complementary and wellness centres are an active acquisition category in the UAE, and they are typically small, owner-managed and bought on multiples of a clean profit line rather than on a diligence pack. The exposure here is not a fine that can be provisioned. It is a licence that does not renew, which ends the business it belongs to.
Any transaction signing or completing before the grace period expires inherits an unsatisfied condition, and where a target licence falls due for renewal after expiry, integration status belongs in the conditions precedent rather than in a post-completion integration plan. A seller who has never been told the exemption lapsed will warrant compliance in good faith and be wrong.
What the circular leaves open
It sets no interim milestones, publishes no technical specification of its own, does not define what falls inside "required patient records and clinical data" for a modality that does not generate hospital-shaped data, and says nothing about centres that change hands mid-period. Those answers come from the onboarding team rather than from the text, which makes a written confirmation of a target's status more useful than any representation in a sale agreement.
Four questions before signing a TCAM acquisition
- Has the target completed technical integration with Malaffi, and what does the onboarding team confirm in writing rather than what does management believe?
- When does each licence in the target group next fall due for renewal, and does that date sit before or after the twelve-month period in Circular 171/2026 expires?
- What does the target's existing practice or clinical system actually emit, and what does integration cost in software, vendor time and clinical administration?
- Are historic patient records complete and in a state that can be submitted, and who carries the cost and the risk if they are not?
The Monday work is short and specific. Pull every DoH licence in the target group with its renewal date. Ask Malaffi's onboarding team to confirm integration status for each site in writing. Scope what the target's clinical system can actually emit, and price the gap. Then decide whether it is a condition precedent or a price adjustment before the seller decides it is neither. That is where our buy-side M&A practice starts on a deal like this.
This brief covers one instrument. The UAE healthcare regulatory tracker carries the full set — DoH, DHA, EDE and the other emirates — with what each one changes and when it takes effect.
Subscribe
The UAE healthcare regulatory briefing
What changed, what it reprices, and the instrument to read. Every second Tuesday. No pitches.
One email a fortnight. Unsubscribe from any of them.